Christopher Causey
Insider
IndividualSelling only9 10b5-1 trades
- 2024
- Jul 23, 2026
- 10
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Causey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Christopher Patusky - $2.73M in UTHR purchases and sales in the last 12 months
- Ray Kurzweil - $2.40M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Causey?
Christopher Causey is a corporate insider of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher Causey submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Christopher Causey been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($3.22M) across all tracked filings.
